Natural Capsules Ltd (NATCAPSUQ) is currently trading at 154.45 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Natural Capsules Limited is an Indian hard capsule shell manufacturer and second-largest gelatin capsule maker domestically, producing gelatin and HPMC capsules from Bengaluru and Puducherry facilities and expanding into steroidal API manufacturing through its subsidiary Natural Biogenex Private Limited. Q1FY27 consolidated revenues were Rs.48.71 crore with EBITDA of Rs.1.12 crore and EBITDA margin of 2.30%; reported PAT remained negative at Rs.(5.74) crore, reflecting elevated finance costs and timing effects from ERP-driven dispatch delays, while on an underlying basis management cites healthy operational performance and improved realizations. NCL is materially scaling its API business: commercial API production at Tumkur has begun, three steroidal APIs received PLI approvals, a greenfield WHO/US/EU‑GMP compliant facility is underway, and contract manufacturing with FermBox Bio has commenced — a strategic move to capture higher-margin, backward‑integrated steroidal API demand. The company is strategically rebalancing capsule production mix toward regulated markets and marquee pharma clients, converting HPMC lines to gelatine temporarily to optimize utilization, and investing in R&D and new high-speed machines; however, interest costs and working capital strain alongside low cash balances remain near-term financial headwinds.

Over the past 52 weeks, Natural Capsules Ltd has traded between a low of ₹137.50 and a high of ₹237.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Natural Capsules Ltd has a market capitalization of approximately 160.80. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Natural Capsules Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of N/A and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 160.80 Cr, Natural Capsules Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Natural Capsules Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Natural Capsules Ltd is N/A. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The 33rd AGM was held on August 12, 2026 via video conferencing (VC/OAVM), starting at 12:10 PM and concluding at 1:00 PM.